Outcomes after delayed and second autologous stem cell transplant in patients with relapsed multiple myeloma

We evaluated the outcomes of 168 patients undergoing delayed or second autologous stem cell transplant (ASCT) for relapsed multiple myeloma (MM) from 2010 to 2019. Overall, 21% ( n = 35) patients had received a prior transplant and 69% ( n = 116) underwent transplant at first relapse. Overall, 27%...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 2021-11, Vol.56 (11), p.2664-2671
Hauptverfasser:	Lemieux, Christopher, Muffly, Lori S., Iberri, David J., Craig, Juliana K., Johnston, Laura J., Lowsky, Robert, Shiraz, Parveen, Rezvani, Andrew R., Frank, Matthew J., Weng, Wen-Kai, Meyer, Everett, Shizuru, Judith A., Arai, Sally, Liedtke, Michaela, Negrin, Robert S., Miklos, David B., Sidana, Surbhi
Format:	Artikel
Sprache:	eng
Schlagworte:	631/67/1990/804 692/699/1541/1990/804 Antineoplastic Combined Chemotherapy Protocols - therapeutic use Autografts Care and treatment Cell Biology Clinical trials Cytogenetics Disease-Free Survival Health services Hematology Hematopoietic Stem Cell Transplantation Humans Internal Medicine Medicine Medicine & Public Health Multiple myeloma Multiple Myeloma - therapy Multivariate analysis Neoplasm Recurrence, Local Patient outcomes Patients Public Health Retrospective Studies Salvage Therapy Stem cell transplantation Stem Cells Therapy Transplantation Transplantation, Autologous
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!